Access cutting-edge obstructive defecation syndrome treatment through this phase 4 clinical trial at a research site in Syracuse. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Syracuse location
Preparing your pre-screening questions…
Access obstructive defecation syndrome specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related obstructive defecation syndrome treatment provided free
Check if you qualify for this obstructive defecation syndrome clinical trial in Syracuse, NY
No-Cost Study Care
Local to Syracuse
Convenient for NY residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The goal of this study is to evaluate whether polyethylene glycol 3350 (PEG3350) versus senna is better at relieving postoperative constipation after urogynecologic surgery. The main questions it aims to answer are: What number of patients taking PEG3350 have obstructed defecation syndrome (ODS), a form of constipation, vs those taking senna in the week after urogynecologic surgery? What patient-level and procedure-level characteristics are associated with postoperative ODS, in patients taking PEG3350 vs senna? participants will: Take their randomized medication daily for seven days after surgery Fill out an ODS questionnaire before and one week after surgery Complete a daily bowel diary for 7 days after surgery
Sponsor: St. Joseph's Health, New York
Inclusion Criteria: * Inclusion criteria includes women scheduled for urogynecologic surgery for pelvic organ prolapse and/or stress urinary incontinence and at least 18 years old. Exclusion Criteria: * Exclusion criteria include undergoing concomitant bowel surgery (colonic resection, anal sphincter repair, rectovaginal fistula repair, rectopexy) or placement of a sacral neuromodulation device alone.
Yes, this clinical trial (NCT06825260) has an active research site in Syracuse, NY that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for obstructive defecation syndrome treatment options in Syracuse, NY, this clinical trial (NCT06825260) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Syracuse research site is actively enrolling participants for this phase 4 clinical trial. You'll receive care from experienced obstructive defecation syndrome specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all obstructive defecation syndrome clinical trials near you to find additional studies recruiting in your area.
See all ulcerative colitis clinical trials recruiting in Syracuse — not just this study.
Browse Ulcerative Colitis Trials in Syracuse →